A randomised controlled clinical trial was performed on 180 pregnant women with indications for labour induction who were divided into 2 groups. Groups 1 each pregnant woman received 50 μg intravaginal misoprostol every 4h (total 250 μg). Group 2 intravenous oxyticin to induce the labour. The successful rate of misoprotol group was 89,89%, higher than oxytocin group- 70%. The interval from induction to vaginal delivery was longer in misoprostol group (8,47± 2,85h verus 6,45± 2,64h)